Objective: To determine factors related to chronic persistent pain lasting more than 6 months after mesh repair for inguinal hernia.
Methodology: This study included 114 patients who underwent elective inguinal hernioplasty at Department of General Surgery, Federal General Hospital, Islamabad, Pakistan from July 2012 to December 2014. All were followed upto end of six months. Postoperatively pain was recorded at second, seventh and fourteen day and at the end of six months on Visual Analogue Scale.
Results: Chronic pain at six-month follow up was present in 37 (32.45%) patients. The incidence of factors responsible for chronic pain were pain before surgery in 22 (19.29%), early postoperative pain in 10 (8.77%) of patients, wound infection in 2 (1.75%), hematoma formation in 3 (2.63%), and seroma formation in 4 (3.508%) patients.
Conclusion: Chronic pain after mesh repair for inguinal hernia causes significant morbidity. Early recognition and management of the factors prevents patient morbidity.
Inguinal Hernia, Mesh Repair, Liechtenstein repair
Clinical potential of tension-lengthening strategies during nerve repair.
Bazarek S, Brown JM, Shah SB
Neural regeneration research. 2022; 17(4): 779-780
Functional and immunological peculiarities of peripheral nerve allografts.
Roballo KCS, Gigley JP, Smith TA, Bittner GD, Bushman JS
Neural regeneration research. 2022; 17(4): 721-727
Oscillating field stimulation promotes axon regeneration and locomotor recovery after spinal cord injury.
Wang YX, Bai JZ, Lyu Z, Zhang GH, Huo XL
Neural regeneration research. 2022; 17(6): 1318-1323
The code of light: do neurons generate light to communicate and repair?
Moro C, Liebert A, Hamilton C, Pasqual N, Jeffery G, Stone J, Mitrofanis J
Neural regeneration research. 2022; 17(6): 1251-1252
Low prevalence of biliary tract cancer with defective mismatch repair genes in a Japanese hospital-based population.
Ando Y, Kumamoto K, Matsukawa H, Ishikawa R, Suto H, Oshima M, Kamada H, Morishita A, Kobara H, Matsunaga T, Haba R, Masaki T, Suzuki Y, Okano K
Oncology letters. 2022; 23(1): 4